Virology News and Research

Latest Virology News and Research

ViraCor-IBT Laboratories launches new influenza and respiratory virus testing service

ViraCor-IBT Laboratories today launched a new, comprehensive influenza and respiratory virus testing service that will assist physicians in detecting a range of respiratory viruses including 2009 Influenza A H1N1, or “swine flu,” as well as other influenza subtypes and common respiratory viruses such as rhinovirus, respiratory syncytial virus (RSV) and human metapneumovirus (HMPV).

31 Aug 2009

D3 Ultra DFA Respiratory Virus Identification Kit can be used for detecting H1N1 virus

Diagnostic HYBRIDS announced that the US Food and Drug Administration has cleared an additional claim for the company's D3 Ultra DFA Respiratory Virus Identification Kit, which confirms that the assay can detect the 2009 influenza A (H1N1)v virus.

31 Aug 2009

Stanford University starts recruiting participants for swine flu vaccine clinical trial

The Stanford University School of Medicine is recruiting participants for a clinical trial to determine the safety of an experimental vaccine against the new H1N1 strain of influenza when the vaccine is combined with an immune-stimulating substance called an adjuvant. The trial will also examine whether use of the adjuvant improves the immune response to the vaccine.

31 Aug 2009

Rite Aid pharmacies to offer regular seasonal flu shots throughout the flu season

Many Rite Aid pharmacists have already been giving regular seasonal flu shots following the Centers for Disease Control and Prevention (CDC) advice that anyone who wishes to reduce the risk of getting the regular seasonal flu get a flu shot as soon as they are available.

31 Aug 2009

Walgreens to provide flue shots faster and easier this season

Walgreens (NYSE:WAG)(NASDAQ:WAG) is making it faster and easier to get a flu shot this season. The nation’s largest drugstore chain today announced it will begin offering seasonal flu shots on Sept. 1 at more than 7,000 points of care nationwide, including nearly all of its stores in 50 states and almost 350 in-store Take Care Clinics.

31 Aug 2009

Seasonal flu shots to be available daily without an appointment at more than 500 MinuteClinic locations

CVS/pharmacy, the nation's leading retail pharmacy, and MinuteClinic, the largest retail health care clinic provider in the U.S., today announced the availability of seasonal flu vaccinations and urged Americans to protect themselves early against the flu. CVS/pharmacy and MinuteClinic are divisions of CVS Caremark (NYSE: CVS), the largest provider of prescriptions in the country.

31 Aug 2009

FDA approves the usage of Valcyte for preventing CMV disease in pediatric patients

Roche announced today that the U.S. Food and Drug Administration (FDA) has approved Valcyte(R) (valganciclovir hydrochloride) for the prevention of cytomegalovirus (CMV) disease in pediatric kidney and heart transplant patients (4 months to 16 years of age) at high risk of developing CMV disease.

31 Aug 2009

Members of the Blue Cross Blue Shield of Arizona to receive coverage for H1N1 vaccine

Blue Cross Blue Shield of Arizona (BCBSAZ) announced today that it will cover the H1N1 vaccine for all BCBSAZ members in addition to its regular coverage of a seasonal flu shot.

29 Aug 2009

Antibiotic functioning as an off switch being developed for gene therapy of Parkinson's disease

A common antibiotic can function as an "off switch" for a gene therapy being developed for Parkinson's disease, according to University of Florida researchers writing online in advance of September's Molecular Therapy.

29 Aug 2009

HIV subtype D infected patients more likely to develop dementia

Patients infected with a particular subtype of HIV, the virus that causes AIDS, are more likely to develop dementia than patients with other subtypes, a study led by Johns Hopkins researchers shows. The finding, reported in the September Clinical Infectious Diseases, is the first to demonstrate that the specific type of HIV has any effect on cognitive impairment, one of the most common complications of uncontrolled HIV infection.

28 Aug 2009

Sinovac to supply its Anflu seasonal flu vaccine to the Beijing Public Health Bureau

Sinovac Biotech Ltd. (NYSE: SVA), a leading provider of biopharmaceutical products in China, announced today that the Beijing Public Health Bureau has selected Sinovac as one of the four manufacturers to supply Anflu(R), Sinovac's seasonal influenza vaccine, for the benefit of the citizens of Beijing. The Beijing Public Health Bureau completed the bidding process for the purchase of flu vaccines and corresponding services for 2009 on August 26, 2009. The agreement will be executed after the public notice period.

28 Aug 2009

Caucasians have a higher rate of HBV recurrence compared to Asian Americans and African Americans

According to the Centers for Disease Control and Prevention (CDC) 1.5 to 2 million Americans are infected with the hepatitis B virus (HBV). Prior studies have shown there to be significant racial differences in access to and outcomes of liver transplantation. Recently, doctors from across the U.S. conducted a multicenter retrospective-prospective study of the waitlist status and outcomes of liver transplant patients with HBV infection.

28 Aug 2009

Maxim Health Systems' website provides detailed information about flu vaccination

Maxim's dedicated flu Web site provides detailed information about the flu vaccination and allows consumers to locate seasonal flu clinics in their area by searching by zip code. In addition, Maxim is preparing to launch several new online resources for consumers to protect themselves and their families this flu season.

28 Aug 2009

Online resource created to help parents, teachers, and school officials to cope with swine flu

Parents, teachers, and school officials are anxiously awaiting the expected return this fall of the H1N1 virus, known as Swine Flu. Declared a pandemic by the World Health Organization, the virus may prove a significant problem to schools and families across the country.

28 Aug 2009

H1N1 virus detected in turkeys

The detection of an H1N1 virus in turkeys in Chile raises concern that poultry farms elsewhere in the world could also become infected with the pandemic flu virus currently circulating in humans, FAO said today.

27 Aug 2009

Majority of Americans are ready to get vaccinated against H1N1 flu virus

A recent poll on the H1N1 flu conducted by the American Red Cross found that more Americans are taking or planning on taking extra measures to cover their coughs and sneezes with tissue (78%) or wash their hands more carefully (76%) to avoid getting the flu.

27 Aug 2009

Lakewood-Amedex to speed up development of its broad spectrum anti-influenza product into clinical studies

Lakewood-Amedex Inc., (L-A), the anti-infectives biopharmaceutical company developing a unique portfolio of anti-bacterial and anti-viral products including NuBiotics, a novel family of synthetic anti-bacterial compounds, and anti-viral products against hepatitis, HIV and influenza, announced today that it is accelerating development of its broad spectrum anti-influenza product into clinical studies.

27 Aug 2009

CDC report predicts that forty percent of Americans may be affected by the H1N1 flu

From summer camps to summer travel, the H1N1 influenza has taken a toll worldwide this season, and experts say the new flu strain is expected to be back in force this fall. Forty percent of Americans could end up being affected by the H1N1 flu, the CDC reported last month.

27 Aug 2009

Relationship between the CD14 variation and the formation of portal lymphoid aggregates discovered

It is still unknown why the natural history of chronic disease caused by hepatitis C virus (HCV), which currently infects 3% of the world's population, varies from mild in some patients to rapidly progressing in others. Age, sex, alcohol consumption and liver sensitivity to gut-derived bacterial endotoxins, were the early factors defined to enhance the risk of fibrosis progression.

27 Aug 2009

Viral polymerase may provide a new therapeutic target for host-adapted avian influenza

Current research suggests that viral polymerase may provide a new therapeutic target for host-adapted avian influenza. The related report by Gabriel et al, "Spread of Infection and Lymphocyte Depletion in Mice Depends on Polymerase of Influenza Virus" appears in the September 2009 issue of the American Journal of Pathology.

26 Aug 2009

Virology News and Research

Latest Virology News and Research

ViraCor-IBT Laboratories launches new influenza and respiratory virus testing service

D3 Ultra DFA Respiratory Virus Identification Kit can be used for detecting H1N1 virus

Stanford University starts recruiting participants for swine flu vaccine clinical trial

Rite Aid pharmacies to offer regular seasonal flu shots throughout the flu season

Walgreens to provide flue shots faster and easier this season

Seasonal flu shots to be available daily without an appointment at more than 500 MinuteClinic locations

FDA approves the usage of Valcyte for preventing CMV disease in pediatric patients

Members of the Blue Cross Blue Shield of Arizona to receive coverage for H1N1 vaccine

Antibiotic functioning as an off switch being developed for gene therapy of Parkinson's disease

HIV subtype D infected patients more likely to develop dementia

Sinovac to supply its Anflu seasonal flu vaccine to the Beijing Public Health Bureau

Caucasians have a higher rate of HBV recurrence compared to Asian Americans and African Americans

Maxim Health Systems' website provides detailed information about flu vaccination

Online resource created to help parents, teachers, and school officials to cope with swine flu

H1N1 virus detected in turkeys

Majority of Americans are ready to get vaccinated against H1N1 flu virus

Lakewood-Amedex to speed up development of its broad spectrum anti-influenza product into clinical studies

CDC report predicts that forty percent of Americans may be affected by the H1N1 flu

Relationship between the CD14 variation and the formation of portal lymphoid aggregates discovered

Viral polymerase may provide a new therapeutic target for host-adapted avian influenza

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production